Figure 3.
First CR. (A) Kaplan-Meier curves were plotted for the entire cohort (N = 32). TTCR was median 77 (range, 19-939; IQR, 31-115) days. There were 31 remission events in the cohort (96.9%). (B) Kaplan-Meier curves for CR were plotted for 2 subgroups: patients with high titer (>20 BU, 14 patients) and low titer (≤20 BU, 18 patients) anti-FVIII antibodies (P = .009). Median follow-up for the cohort was 779.5 (range, 27-3319; IQR, 455.5-1868.2) days.

First CR. (A) Kaplan-Meier curves were plotted for the entire cohort (N = 32). TTCR was median 77 (range, 19-939; IQR, 31-115) days. There were 31 remission events in the cohort (96.9%). (B) Kaplan-Meier curves for CR were plotted for 2 subgroups: patients with high titer (>20 BU, 14 patients) and low titer (≤20 BU, 18 patients) anti-FVIII antibodies (P = .009). Median follow-up for the cohort was 779.5 (range, 27-3319; IQR, 455.5-1868.2) days.

Close Modal

or Create an Account

Close Modal
Close Modal